The DOI matches its Crossref record; 2,264 of the 2,264 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 801–1,000 of 2,264
Doly, S., Fischer, J., Brisorgueil, M., Vergé, D., & Conrath, M. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20667 · Cited by 129
Gunthorpe, M. J., & Lummis, S. C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009575200 · Cited by 129
Self-citationJaffré, F., Bonnin, P., Callebert, J., Debbabi, H., Setola, V., Doly, S., Monassier, L., Mettauer, B., Blaxall, B. C., Launay, J., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.180976 · Cited by 129
Self-citationmCPP-induced anxiety in the light-dark box in rats - a new method for screening anxiolytic activity
Bilkei‐Gorzó, A., Gyertyán, I., & Lévay, G. I. (1998) · Psychopharmacology · doi:10.1007/s002130050568 · Cited by 129
Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth
Duhr, F., Déléris, P., Raynaud, F., Sevéno, M., Morisset‐Lopez, S., la Cour, C. M., Millan, M. J., Bockaert, J., Marin, P., & Chaumont‐Dubel, S. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1547 · Cited by 129
Self-citationRS‐127445: a selective, high affinity, orally bioavailable 5‐HT2B receptor antagonist
Bonhaus, D. W., Flippin, L. A., Greenhouse, R., Jaime, S., Rocha, C., Dawson, M. A., Natta, K. V., Chang, L. K., Pulido‐Rios, T., Webber, A., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702632 · Cited by 129
Mast cells and inflammatory mediators in chronic ulcerative colitis
Stoyanova, I. I., & Gulubova, M. V. (2002) · Acta Histochemica · doi:10.1078/0065-1281-00641 · Cited by 129
Fletcher, P. J., Chintoh, A. F., Sinyard, J., & Higgins, G. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300319 · Cited by 129
Bubar, M. J., & Cunningham, K. A. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778522131 · Cited by 129
Self-citationVines, A., Delattre, A. M., Lima, M. M. S., Rodrigues, L. S., Suchecki, D., Machado, R. B., Tufik, S., Pereira, S. I. R., Zanata, S. M., & Ferraz, A. C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.017 · Cited by 129
Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry
Vilaró, M. T., Cortés, R., Gerald, C., Branchek, T. A., Palacios, J. M., & Mengod, G. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00248-3 · Cited by 128
Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects
Kessing, B., Smout, A. J., Bennink, R., Kraaijpoel, N., Oors, J., & Bredenoord, A. (2014) · Neurogastroenterology and Motility · doi:10.1111/nmo.12359 · Cited by 128
Newman‐Tancredi, A., Martel, J.-C., Assié, M. B., Buritova, J., Lauressergues, E., Cosi, C., Heusler, P., Slot, L. A. B., Colpaert, F. C., Vacher, B., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00001.x · Cited by 128
Self-citationThematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease
Nelson, R. K., & Frohman, M. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r059220 · Cited by 128
Kolodziejczak, M., Béchade, C., Gervasi, N., Irinopoulou, T., Banas, S. M., Cordier, C., Rebsam, A., Roumier, A., & Maroteaux, L. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5003489 · Cited by 128
Self-citationS100B and response to treatment in major depression: a pilot study
Arolt, V., Peters, M., Erfurth, A., Wiesmann, M., Missler, U., Rudolf, S., Kirchner, H., & Rothermundt, M. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00016-6 · Cited by 128
Heidmann, D., Szot, P., Kohen, R., & Hamblin, M. W. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00070-7 · Cited by 128
5-HT2Areceptors: location and functional analysis in intestines of wild-type and 5-HT2Aknockout mice
Fiorica‐Howells, E., Hen, R., Gingrich, J. A., Li, Z., & Gershon, M. D. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00435.2001 · Cited by 128
Self-citationMorecroft, I., Dempsie, Y., Bäder, M., Walther, D. J., Kotnik, K., Loughlin, L., Nilsen, M., & MacLean, M. R. (2006) · Hypertension · doi:10.1161/01.hyp.0000252210.58849.78 · Cited by 128
Serotonergic mediation of postprandial colonic tonic and phasic responses in humans.
von der Ohe, M. R., Hanson, R. B., & Camilleri, M. (1994) · Gut · doi:10.1136/gut.35.4.536 · Cited by 128
Self-citationMice with altered serotonin 2C receptor RNA editing display characteristics of Prader–Willi syndrome
Morabito, M. V., Abbas, A. I., Hood, J. L., Kesterson, R. A., Jacobs, M. M., Kump, D. S., Hachey, D. L., Roth, B. L., & Emeson, R. B. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.004 · Cited by 127
Self-citationIon permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells.
Yang, J. P. (1990) · The Journal of General Physiology · doi:10.1085/jgp.96.6.1177 · Cited by 127
Serotonin pharmacology in the gastrointestinal tract: a review
Beattie, D. T., & Smith, J. A. M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0276-9 · Cited by 126
Palfreyman, M. G., Schmidt, C. J., Sorensen, S. M., Dudley, M. W., Kehne, J. H., Moser, P. C., Gittos, M. W., & Carr, A. A. (1993) · Psychopharmacology · doi:10.1007/bf02245008 · Cited by 126
Ion permeation and conduction in a human recombinant 5‐HT3 receptor subunit (h5‐HT3A)
Brown, A. M., Hope, A. G., Lambert, J. J., & Peters, J. A. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.653bs.x · Cited by 126
Nilsson, T., Longmore, J., Shaw, D. E., Olesen, I. J., & Edvinsson, L. I. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702773 · Cited by 125
The 5-HT7 receptor is involved in allocentric spatial memory information processing
Sarkisyan, G., & Hedlund, P. B. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.011 · Cited by 125
Thomas, E. A., Carson, M. J., Neal, M. J., & Sutcliffe, J. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14115 · Cited by 125
Bach, T., Syversveen, T., Kvingedal, A. M., Krobert, K. A., Brattelid, T., Kaumann, A. J., & Levy, F. O. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000299 · Cited by 125
Self-citationGiovanni, G. D., Matteo, V. D., Grutta, V. L., & Esposito, E. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00561-3 · Cited by 125
Borsini, F., Evans, K., Jason, K., Rohde, F., Alexander, B., & Pollentier, S. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00219.x · Cited by 125
Fontana, D., Daniels, S. E., Wong, E. H. F., Clark, R. D., & Eglen, R. M. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00055-5 · Cited by 125
Herrick‐Davis, K., Grinde, E., Cowan, A. E., & Mazurkiewicz, J. E. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087072 · Cited by 125
Self-citationThe serotonin 5‐HT 2B receptor controls bone mass via osteoblast recruitment and proliferation
Collet, C., Schiltz, C., Geoffroy, V., Maroteaux, L., Launay, J., & de Vernejoul, M. C. (2007) · The FASEB Journal · doi:10.1096/fj.07-9209com · Cited by 125
Self-citationThe importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives.
Newman‐Tancredi, A. (2010) · PubMed · Cited by 124
Self-citationCloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.
Belelli, D., Balcarek, J. M., Hope, A. G., Peters, J. A., Lambert, J. J., & Blackburn, T. P. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10574-9 · Cited by 124
McCall, R. B., Patel, B., & Harris, L. T. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39169-x · Cited by 124
Jaunarajs, K. L. E., Dupre, K. B., Barnum, C. J., Dickinson, S. O., Park, J. Y., & Bishop, C. (2009) · Synapse · doi:10.1002/syn.20630 · Cited by 124
Xie, Z., Lee, S. P., O’Dowd, B. F., & George, S. R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00918-7 · Cited by 124
Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine
Grottick, A. J., Corrigall, W., & Higgins, G. A. (2001) · Psychopharmacology · doi:10.1007/s002130100801 · Cited by 124
Mpdz is a quantitative trait gene for drug withdrawal seizures
Shirley, R. L., Walter, N. A. R., Reilly, M. T., Fehr, C., & Buck, K. J. (2004) · Nature Neuroscience · doi:10.1038/nn1271 · Cited by 124
Marek, G. J., Martín‐Ruiz, R., Abo, A., & Artigas, F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300762 · Cited by 124
Horiguchi, M., Huang, M., & Meltzer, H. Y. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180638 · Cited by 124
5‐HT2B receptors play a key role in mediating the excitatory effects of 5‐HT in human colon in vitro
Borman, R. A., Tilford, N. S., Harmer, D. W., Day, N. C., Ellis, E. S., Sheldrick, R. L. G., Carey, J. E., Coleman, R. A., & Baxter, G. S. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704571 · Cited by 124
Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor
Basak, S., Gicheru, Y. W., Rao, S., Sansom, M. S. P., & Chakrapani, S. (2018) · Nature · doi:10.1038/s41586-018-0660-7 · Cited by 124
Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
Łukasiewicz, S., Polit, A., Kędracka–Krok, S., Wędzony, K., Maćkowiak, M., & Dziedzicka‐Wasylewska, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.010 · Cited by 123
Slot, L. A. B., Kleven, M. S., & Newman‐Tancredi, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.05.013 · Cited by 123
Self-citationMoreau, J., Bös, M., Jenck, F., Martin, J. R., Mortas, P., & Wichmann, J. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)00015-6 · Cited by 123
5-HT2C Receptors Localize to Dopamine and GABA Neurons in the Rat Mesoaccumbens Pathway
Bubar, M. J., Stutz, S. J., & Cunningham, K. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020508 · Cited by 123
Self-citationConnor, H., Feniuk, W., Beattie, D. T., North, P., Oxford, A., Saynor, D. A., & Humphrey, P. P. A. (1997) · Cephalalgia · doi:10.1046/j.1468-2982.1997.1703145.x · Cited by 123
Inhibitory Effect of Hippocampal 5-HT1A Receptors on Human Explicit Memory
Yasuno, F., Suhara, T., Nakayama, T., Ichimiya, T., Okubo, Y., Takano, A., Ando, T., Inoue, M., Maeda, J., & Suzuki, K. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.334 · Cited by 123
Activation of Serotonin 2C Receptors in Dopamine Neurons Inhibits Binge-like Eating in Mice
Xu, P., He, Y., Cao, X., Valencia-Torres, L., Yan, X., Saito, K., Wang, C., Yang, Y., Hinton, A. O., Jr., Zhu, L., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.06.005 · Cited by 123
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Wainscott, D. B., Cohen, M. L., Schenck, K. W., Audia, J. E., Nissen, J. S., Baez, M., Kursar, J. D., Lucaites, V. L., & Nelson, D. L. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13628-6 · Cited by 122
Self-citationDistinct Circuits Underlie the Effects of 5-HT1B Receptors on Aggression and Impulsivity
Nautiyal, K. M., Tanaka, K. F., Barr, M. M., Tritschler, L., Dantec, Y. L., David, D. J. P., Gardier, A. M., Blanco, C., Hen, R., & Ahmari, S. E. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.041 · Cited by 122
Serotonin, Eating Behavior, and Fat Intake
Blundell, J. E., Lawton, C. L., & Halford, J. C. G. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00214.x · Cited by 122
The 5‐HT4 receptor agonist, tegaserod, is a potent 5‐HT2B receptor antagonist in vitro and in vivo
Beattie, D. T., Smith, J. A. M., Marquess, D. G., Vickery, R. G., Armstrong, S. R., Pulido‐Rios, T., McCullough, J. L., Sandlund, C., RICHARDSON, C. E., Mai, N., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705929 · Cited by 122
Rodent models of aggressive behavior and serotonergic drugs
Olivier, B., & Mos, J. (1992) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(92)90104-m · Cited by 122
Hodge, J. M., Wang, Y., Berk, M., Collier, F. M., Fernandes, T. J., Constable, M. J., Pasco, J. A., Dodd, S., Nicholson, G. C., Kennedy, R. L., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.003 · Cited by 122
Varnäs, K., Thomas, D. R., Tupala, E., Tiihonen, J., & Hall, H. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.025 · Cited by 122
Martinez, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00187-1 · Cited by 122
Watts, S. W. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21317-9 · Cited by 121
Self-citationBrain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors.
Huidobro-Toro, J. P., & Harris, R. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8078 · Cited by 121
Ghrelin’s Orexigenic Effect Is Modulated via a Serotonin 2C Receptor Interaction
Schellekens, H., Francesco, P. N. D., Kandil, D., Theeuwes, W. F., McCarthy, T., van Oeffelen, W. E. P. A., Perelló, M., Giblin, L., Dinan, T. G., & Cryan, J. F. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500318q · Cited by 120
Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia
Pouzet, B., Didriksen, M., & Arnt, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00744-4 · Cited by 120
Therapeutics of 5-HT3 receptor antagonists: Current uses and future directions
Machu, T. K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.02.003 · Cited by 120
Gating of Pentameric Ligand-Gated Ion Channels: Structural Insights and Ambiguities
daCosta, C. J. B., & Baenziger, J. E. (2013) · Structure · doi:10.1016/j.str.2013.06.019 · Cited by 120
Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy
Albert, P. R. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00035 · Cited by 120
Cryo-EM structure of 5-HT3A receptor in its resting conformation
Basak, S., Gicheru, Y. W., Samanta, A., Molugu, S. K., Huang, W., Fuente, M., Hughes, T. E. T., Taylor, D. J., Nieman, M. T., Moiseenkova‐Bell, V. Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02997-4 · Cited by 120
Mediation of 5‐hydroxytryptamine‐induced tachycardia in the pig by the putative 5‐HT4 receptor
Villalón, C. M., den Boer, M. O., Heiligers, J. P. C., & Saxena, P. R. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14073.x · Cited by 119
Self-citationRS 67333 and D-cycloserine accelerate learning acquisition in the rat
Lelong‐Boulouard, V., Dauphin, F., & Boulouard, M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00085-5 · Cited by 119
Pindon, A., Hecke, G. V., Gompel, P. V., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.85 · Cited by 119
Vázquez, P. M., Cortés, R., & Artigas, F. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn204 · Cited by 119
Gooz, M. B., Göőz, P., Luttrell, L. M., & Raymond, J. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512096200 · Cited by 119
5-HT4Receptor Ligands: Applications and New Prospects
Langlois, M., & Fischmeister, R. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020099f · Cited by 119
Selectivity of serotonergic drugs for multiple brain serotonin receptors
Titeler, M., Lyon, R. A., Davis, K. H., & Glennon, R. A. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90643-5 · Cited by 118
Tonini, M., Galligan, J. J., & North, R. A. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80012-5 · Cited by 118
[3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain
Waeber, C., Sebben, M., Grossman, C. P., Javoy-Agid, F., Bockaert, J., & Dumuis, A. (1993) · Neuroreport · doi:10.1097/00001756-199309000-00007 · Cited by 118
Self-citationTargeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice
Kelley, S. P., Bratt, A. M., & Hodge, C. W. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02960-6 · Cited by 118
Amisulpride versus imipramine and placebo in dysthymia and major depression
Lecrubier, Y., Boyer, P., Turjanski, S., & Rein, W. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)00103-6 · Cited by 118
Serotonin receptor mRNA expression in rat dorsal root ganglion neurons
Nicholson, R., Small, J., Dixon, A. K., Spanswick, D. C., & Lee, K. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01256-9 · Cited by 118
BW 723C86, a 5-HT2B Receptor Agonist, Causes Hyperphagia and Reduced Grooming in Rats
Kennett, G. A., Ainsworth, K., Trail, B. K., & Blackburn, T. P. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00171-2 · Cited by 118
Hamblin, M. W., Metcalf, M. A., McGuffin, R. W., & Karpells, S. T. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90654-4 · Cited by 118
Neal, K., Parry, L. J., & Bornstein, J. C. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160416 · Cited by 118
Banes, A. K., Florian, J. A., & Watts, S. W. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35225-5 · Cited by 118
Self-citationWainscott, D. B., Lucaites, V. L., Kursar, J. D., Baez, M., & Nelson, D. L. G. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12346-x · Cited by 118
Self-citationBonnin, A., Peng, W., Hewlett, W., & Levitt, P. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.036 · Cited by 117
Lladó-Pelfort, L., Assié, M. B., Newman‐Tancredi, A., Artigas, F., & Celada, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00738.x · Cited by 117
Self-citationInhibition of Serotonin 5-Hydroxytryptamine2C Receptor Function through Heterodimerization
Herrick‐Davis, K., Grinde, E., Harrigan, T. J., & Mazurkiewicz, J. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507396200 · Cited by 117
Self-citationSerotonin 5-HT2C Receptor Homodimer Biogenesis in the Endoplasmic Reticulum
Herrick‐Davis, K., Weaver, B. A., Grinde, E., & Mazurkiewicz, J. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604390200 · Cited by 117
Self-citationBaker, L. P., Nielsen, M. D., Impey, S., Metcalf, M. A., Poser, S., Chan, G. C. ‐., Obrietan, K. H., Hamblin, M. W., & Storm, D. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17469 · Cited by 117
Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients
Lorke, D. E., Lü, G., Cho, E. Y. P., & Yew, D. T. W. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-36 · Cited by 117
Jones, M. D., & Lucki, I. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300664 · Cited by 117
Wesołowska, A., Nikiforuk, A., & Stachowicz, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.064 · Cited by 117
DARPP-32 mediates serotonergic neurotransmission in the forebrain
Svenningsson, P., Tzavara, E. T., Liu, F., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052712699 · Cited by 117
Lambe, E. K., & Aghajanian, G. K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09955.2001 · Cited by 117
Self-citationPharmacological profile of novel psychoactive benzofurans
Rickli, A., Kopf, S., Hoener, M. C., & Liechti, M. E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13128 · Cited by 116
Epilepsy and Obesity in Serotonin 5‐HT2C Receptor Mutant Mice
Heisler, L. K., Chu, H.-M., & Tecott, L. H. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10175.x · Cited by 116
5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture
Sebben, M., Ansanay, H., Bockaert, J., & Dumuis, A. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00037 · Cited by 116
Self-citationGelber, E. I., Kroeze, W. K., Roth, B. L., Gray, J. A., Sinar, C. A., Hyde, E. G., Gurevich, V. V., Benovic, J., & Roth, B. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722206.x · Cited by 116
Self-citationOligomerization of Dopamine and Serotonin Receptors
Lee, S. P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00155-x · Cited by 116
Identification of Biomarkers of Adrenocortical Carcinoma Using Genomewide Gene Expression Profiling
Fernandez-Ranvier, G. G., Weng, J., Yeh, R.-F., Khanafshar, E., Suh, I., Barker, C., Duh, Q. Y., Clark, O. H., & Kebebew, E. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.9.841 · Cited by 116
Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices
G�thert, M., & Weinheimer, G. (1979) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00499879 · Cited by 116
Fletcher, P. J., Rizos, Z., Sinyard, J., Tampakeras, M., & Higgins, G. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301509 · Cited by 116
Meneses, A. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.04.026 · Cited by 116
Moser, P. C., Bergis, O. E., Jegham, S., Lochead, A. W., Duconseille, E., Terranova, J.-P., Caille, D., Berque‐Bestel, I., Lezoualc’h, F., Fischmeister, R., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034249 · Cited by 116
Self-citationLucki, I. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80055-7 · Cited by 115
Pelloux, Y., Dilleen, R., Economidou, D., Theobald, D. E. H., & Everitt, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.111 · Cited by 115
Ciranna, L., & Catania, M. V. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00250 · Cited by 115
Serotonylation of Vascular Proteins Important to Contraction
Watts, S. W., Priestley, J. R. C., & Thompson, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005682 · Cited by 115
Self-citationMoya, P. R., Berg, K. A., Gutierrez-Hernandez, M., Sáez‐Briones, P., Reyes-Parada, M. I., Cassels, B. K., & Clarke, W. P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117507 · Cited by 115
Boehme, S. A., Lio, F. M., Sikora, L., Pandit, T. S., Lavrador, K., Sriramarao, P., & Sriramarao, P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3599 · Cited by 115
Choudhary, M. S., Craigo, S., & Roth, B. L. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13653-5 · Cited by 115
Self-citationPresynaptic inhibition of glutamatergic synaptic transmission to rat motoneurons by serotonin
Singer, J. H., Bellingham, M. C., & Berger, A. J. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.2.799 · Cited by 114
First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635
Pike, V. W., McCarron, J. A., Lammertsma, A. A., Hume, S. P., Poole, K., Grasby, P. M., Malizia, A. L., Cliffe, I. A., Fletcher, A., & Bench, C. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00438-q · Cited by 114
Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors
Newman‐Tancredi, A., Chaput, C., Verrièle, L., & Millan, M. J. (1996) · Neuropharmacology · doi:10.1016/0028-3908(95)00170-0 · Cited by 114
Self-citationThe 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior
Sarkisyan, G., Roberts, A. J., & Hedlund, P. B. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.022 · Cited by 114
Self-citationSerotonin 2A Receptor Agonist Binding in the Human Brain with [ 11 C]Cimbi-36
Ettrup, A., da Cunha-Bang, S., McMahon, B., Lehel, S., Dyssegaard, A., Skibsted, A. P., Jørgensen, L. M., Hansen, M. A., Baandrup, A. O., Bache, S., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.68 · Cited by 114
Jansen, M., Bali, M., & Akabas, M. H. (2008) · The Journal of General Physiology · doi:10.1085/jgp.200709896 · Cited by 114
Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense.
Gershon, M. D. (2012) · PubMed · Cited by 114
Self-citationSaylor, D. R., & McArthur, J. C. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.557 · Cited by 114
Glennon, R. A., Raghupathi, R., Bartyzel, P., Teitler, M., & Leonhardt, S. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00082a014 · Cited by 113
Self-citationAssié, M., Bardin, L., Auclair, A. L., Carilla-Durand, E., Depoortère, R., Koek, W., Kleven, M. S., Colpaert, F. C., Vacher, B., & Newman‐Tancredi, A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991222 · Cited by 113
Self-citationHormones of the gut–brain axis as targets for the treatment of upper gastrointestinal disorders
Sanger, G. J., & Lee, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2444 · Cited by 113
Self-citationKhawaja, X. Z. (1995) · Brain Research · doi:10.1016/0006-8993(94)01416-f · Cited by 113
Cussac, D., Boutet-Robinet, E. A., Ailhaud, M., Newman‐Tancredi, A., Martel, J., Danty, N., & Rauly‐Lestienne, I. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.040 · Cited by 113
Self-citationVarnäs, K., Hall, H., Bonaventure, P., & Sedvall, G. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02823-2 · Cited by 113
A 5-HT4-like receptor in human right atrium
Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., & Brown, M. J. (1991) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00167212 · Cited by 113
Possible Antimigraine Mechanisms of Action of the 5HT1F Receptor Agonist LY334370
Shepheard, S. L., Edvinsson, L. I., Cumberbatch, M. J., Williamson, D., Mason, G. S., Webb, J. K., Boyce, S., Hill, R., & Hargreaves, R. J. (1999) · Cephalalgia · doi:10.1046/j.1468-2982.1999.1910851.x · Cited by 113
Reynolds, G. P., Arranz, B., Templeman, L. A., Fertuzinhos, S., & San, L. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1826 · Cited by 113
Cellular mechanisms of the 5-HT7receptor-mediated signaling
Guseva, D., Wirth, A., & Ponimaskin, E. G. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00306 · Cited by 112
Patel, B. A., Bian, X., Quaiserová‐Mocko, V., Galligan, J. J., & Swain, G. M. (2006) · The Analyst · doi:10.1039/b611920d · Cited by 112
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs
Meltzer, H. Y., & Roth, B. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70678 · Cited by 112
Self-citationCunningham, K. A., Fox, R. G., Anastasio, N. C., Bubar, M. J., Stutz, S. J., Moeller, F. G., Gilbertson, S. R., & Rosenzweig-Lipson, S. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.034 · Cited by 112
Self-citationRNA Editing of the Human Serotonin 5-HT2CReceptor Alters Receptor-mediated Activation of G13Protein
Price, R. D., Weiner, D. M., Chang, M., & Sanders‐Bush, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106745200 · Cited by 112
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
Aloyo, V. J., Berg, K. A., Spampinato, U., Clarke, W. P., & Harvey, J. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.010 · Cited by 112
Convulsive ergotism: epidemics of the serotonin syndrome?
Eadie, M. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00439-3 · Cited by 112
Ma, Q., Hill, R., & Sirinathsinghji, D. J. S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01586.x · Cited by 112
Dynamics of β2-Adrenergic Receptor−Ligand Complexes on Living Cells
Hegener, O., Prenner, L., Runkel, F., Baader, S. L., Kappler, J., & Häberlein, H. (2004) · Biochemistry · doi:10.1021/bi035928t · Cited by 112
Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene
Flomen, R. H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh536 · Cited by 111
Krobert, K. A., & Levy, F. O. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704588 · Cited by 111
Self-citationErrico, M., Crozier, R. A., Plummer, M. R., & Cowen, D. S. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00460-7 · Cited by 111
Effects of the 5‐HT2B receptor agonist, BW 723C86, on three rat models of anxiety
Kennett, G. A., Bright, F., Trail, B. K., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15304.x · Cited by 111
Plasticity in serotonin control mechanisms in the gut
Gershon, M. D. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.07.005 · Cited by 111
Self-citationPindolol Augmentation of Antidepressant Response
Artigas, F., Adell, A., & Celada, P. (2006) · Current Drug Targets · doi:10.2174/138945006775515446 · Cited by 111
Hagena, H., & Manahan‐Vaughan, D. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.06.014 · Cited by 111
The Serotonin Hypothesis of Pulmonary Hypertension Revisited
MacLean, M. R., & Dempsie, Y. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-60761-500-2_20 · Cited by 110
Talley, N. J., ZANTEN, S. V. V., Saez, L. R., Dukes, G. E., Perschy, T. L., Heath, M., Kleoudis, C. S., & Mangel, A. W. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00941.x · Cited by 110
Centrally active 5-HT receptor agonists and antagonists
Middlemiss, D. N., & Tricklebank, M. D. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80054-5 · Cited by 110
Navailles, S., Moison, D., Cunningham, K. A., & Spampinato, U. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301414 · Cited by 110
Self-citationElangbam, C. S., Job, L. E., Zadrozny, L. M., Barton, J. C., Yoon, L., Gates, L. D., & Slocum, N. (2008) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2008.03.005 · Cited by 110
5-HT1A receptors: Differential involvement in female and male sexual behavior in the rat
Mendelson, S. D., & Gorzalka, B. B. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90244-1 · Cited by 110
Localization of 5-ht5A receptor-like immunoreactivity in the rat brain
Oliver, K. R., Kinsey, A. M., Wainwright, A., & SIRINATHSINGHJI, D. J. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02273-3 · Cited by 109
Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents
Rosenzweig-Lipson, S. J., Sabb, A. L., Stack, G., Mitchell, P., Lucki, I., Malberg, J. E., Grauer, S. M., Brennan, J. A., Cryan, J. F., Rizzo, S. J. S., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0710-6 · Cited by 109
Isolation of a mouse “5HT1E-like” serotonin receptor expressed predominantly in hippocampus.
Amlaiky, N., Ramboz, S., Boschert, U., Plassat, J., & Hen, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88617-9 · Cited by 109
Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop
Kohen, R., Fashingbauer, L. A., Heidmann, D., et al. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00090-0 · Cited by 109
Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites
Hamik, A., Oksenberg, D., Fischette, C. T., & Peroutka, S. J. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90627-e · Cited by 109
Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleepsstages and EEG power spectra
Dijk, D., Beersma, D. G. M., Daan, S., & van den Hoofdakker, R. H. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90109-x · Cited by 109
Cornea-Hébert, V., Watkins, K. C., Roth, B. L., Kroeze, W. K., Gaudreau, P., Leclerc, N. M., & Descarries, L. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00146-x · Cited by 109
Self-citationFibrosis and carcinoid syndrome: from causation to future therapy
Druce, M. R., Rockall, A., & Grossman, A. B. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.51 · Cited by 109
Loiseau, F., Dekeyne, A., & Millan, M. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0934-5 · Cited by 109
GORE, S., Gilmore, I. T., Haigh, C. G., Brownless, S. M., Stockdale, H. R., & Morris, A. I. (1990) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1990.tb00458.x · Cited by 109
Serotonin-2 Receptors and Human Sleep Effect of a Selective Antagonist on EEG Power Spectra
Landolt, H., Meier, V., Burgess, H. J., Finelli, L. A., Cattelin, F., Achermann, P., & Borbély, A. A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00052-4 · Cited by 108
Identification of a novel family of G protein‐coupled receptor associated sorting proteins
Simonin, F., Karcher, P., Boeuf, J., Matifas, A., & Kieffer, B. L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02411.x · Cited by 108
Differential modulation of the 5-HT4 receptor agonists and antagonist on rat learning and memory
Marchetti, E., Dumuis, A., Bockaert, J., Soumireu-Mourat, B., & Roman, F. S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00038-1 · Cited by 108
Self-citationAn expression screen reveals modulators of class II histone deacetylase phosphorylation
Chang, S., Bezprozvannaya, S., Li, S., & Olson, E. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503275102 · Cited by 108
Martín‐Cora, F., & Pazos, Á. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705576 · Cited by 108
Anxiolytic Potential of 5‐HT3 Receptor Antagonists
Costall, B., & Naylor, R. J. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb00448.x · Cited by 108
Xie, E., Zhu, L., Zhao, L., & Chang, L. (1996) · Genomics · doi:10.1006/geno.1996.0397 · Cited by 108
Kaya, N., Shen, T., Lu, S., Zhao, F., & Herness, S. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00572.2003 · Cited by 108
Buckland, P. R., Hoogendoorn, B., Guy, C., Smith, S. K., Coleman, S. L., & O’Donovan, M. C. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.613 · Cited by 108
Azmitia, E. C., Singh, J. S., & Whitaker-Azmitia, P. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.002 · Cited by 107
Zhang, Y., Damjanoska, K. J., Carrasco, G. A., Dudas, B., D'Souza, D. N., Tetzlaff, J., Garcia, F., Hanley, N. R. S., Scripathirathan, K., Petersen, B. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09635.2002 · Cited by 107
Waeber, C., & Moskowitz, M. A. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168556 · Cited by 107
Bardin, L., Kleven, M. S., Barret-Grévoz, C., Depoortère, R., & Newman‐Tancredi, A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300940 · Cited by 107
Self-citationMapping of serotonin 5-HT4 receptor mRNA and ligand binding sites in the post-mortem human brain
Bonaventure, P., Hall, H., Gommeren, W., Cras, P. P., Langlois, X., Jurzak, M., & Leysen, J. E. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200004)36:1<35::aid-syn4>3.0.co;2-y · Cited by 107
Gill, R. K., Saksena, S., Tyagi, S., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.011 · Cited by 107
5-HT1A receptor influences on rodent social and agonistic behavior: A review and empirical study
Bell, R., & Hobson, H. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90046-9 · Cited by 107
Yocca, F. D., Iben, L. G., & Meller, E. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09248-x · Cited by 107
Brain edema induced by in vitro ischemia: causal factors and neuroprotection
MacGregor, D. G., Avshalumov, M. V., & Rice, M. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01772.x · Cited by 106
Filip, M., & Cunningham, K. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00741-9 · Cited by 106
Self-citationDual Role of the RIC-3 Protein in Trafficking of Serotonin and Nicotinic Acetylcholine Receptors
Castillo, M., Mulet, J. M., Gutiérrez, L. M., Ortiz, J. A., Castelán, F., Gerber, S., Sala, S., Sala, F., & Criado, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503746200 · Cited by 106
Hamblin, M. W., McGuffin, R. W., Metcalf, M. A., Dorsa, D. M., & Merchant, K. M. (1992) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(92)90070-i · Cited by 106
Global Increases in Seizure Susceptibility in Mice Lacking 5-HT2CReceptors: A Behavioral Analysis
Applegate, C. D., & Tecott, L. H. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6901 · Cited by 106
Nausea and the quest for the perfect anti-emetic
Andrews, P. L. R., & Sanger, G. J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.072 · Cited by 106
Self-citationPascual-Brazo, J., Castro, E., Díaz, Á., Valdizán, E. M., Pilar-Cuéllar, F., Vidal, R., Treceño, B., & Pazos, Á. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000782 · Cited by 106
Kulla, A., & Manahan‐Vaughan, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.2.150 · Cited by 106
Sleep and Sleep Homeostasis in Mice Lacking the 5-HT2c Receptor
Frank, M. G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00353-6 · Cited by 106
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
Fabre, A., Marchal-Sommé, J., Marchand-Adam, S., Quesnel, C., Borie, R., Dehoux, M., Ruffié, C., Callebert, J., Launay, J., Hénin, D., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00126907 · Cited by 106
Kawahara, Y., Grimberg, A., Teegarden, S., Mombereau, C., Liu, S., Bale, T. L., Blendy, J. A., & Nishikura, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3896-08.2008 · Cited by 105
Wood, M. D., Reavill, C., Trail, B. K., Wilson, A. W., Stean, T. O., Kennett, G. A., Lightowler, S., Blackburn, T. P., Thomas, D. W., Gager, T., et al. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00054-5 · Cited by 105
Making a neuron: Cdk5 in embryonic and adult neurogenesis
Jessberger, S., Gage, F. H., Eisch, A. J., & Lagace, D. C. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.07.002 · Cited by 105
Bersani, G., Grispini, A., Marini, S., Pasini, A., Valducci, M., & Ciani, N. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199012000-00003 · Cited by 105
Brown, P. M., Drossman, D. A., Wood, A. J. J., Cline, G. A., Frazier, K., Jackson, J., Bronner, J., Freiman, J. P., Zambrowicz, B., Sands, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.005 · Cited by 105
Self-citationVisualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography
Waeber, C., Dietl, M. M., Hoyer, D., Probst, A., & Palacios, J. M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90307-2 · Cited by 105
Self-citationRegulation of dorsal raphe nucleus function by serotonin autoreceptors: A behavioral perspective
McDevitt, R. A., & Neumaier, J. F. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.05.001 · Cited by 105
Self-citationRas-dependent ERK Activation by the Human Gs-coupled Serotonin Receptors 5-HT4(b) and 5-HT7(a)
Norum, J. H., Hart, K., & Levy, F. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206237200 · Cited by 105
Self-citation−759C/genetic variation of 5HT2C receptor and clozapine-induced weight gain
Basile, V. S., Masellis, M., Luca, V. D., Meltzer, H. Y., & Kennedy, J. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11706-5 · Cited by 105
Short‐chain fatty acid sensing in rat duodenum
Akiba, Y., Inoue, T., Kaji, I., Higashiyama, M., Narimatsu, K., Iwamoto, K., Watanabe, M., Guth, P. H., Engel, E., Kuwahara, A., et al. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.280792 · Cited by 105
Kadowaki, M., Wade, P. R., & Gershon, M. D. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.5.g849 · Cited by 105
Self-citationSerotonin: Imaging Findings in Eating Disorders
Bailer, U. F., & Kaye, W. H. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_78 · Cited by 104
Cited by
Tryptophan metabolism and gut-brain homeostasis
Roth, W., Zadeh, K., Vekariya, R., Ge, Y., & Mohamadzadeh, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062973 · Cited by 519
Structural insights into the lipid and ligand regulation of serotonin receptors
Xu, P., Huang, S., Zhang, H., Mao, C., Zhou, X. E., Cheng, X., Simon, I. A., Shen, D.-D., Yen, H.-Y., Robinson, C. V., et al. (2021) · Nature · doi:10.1038/s41586-021-03376-8 · Cited by 270
The neurobiology of social play behaviour: Past, present and future
Achterberg, E. J. M., & Vanderschuren, L. J. M. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105319 · Cited by 56
Metadata
- Authors
- Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., Di Giovanni, G., Goodfellow, N. M., Halberstadt, A. L., Hartley, R. M., Hassaine, G., Herrick-Davis, K., Hovius, R., Lacivita, E., Lambe, E. K., Leopoldo, M., Levy, F. O., Lummis, S. C. R., Marin, P., Maroteaux, L., McCreary, A. C., Nelson, D. L., Neumaier, J. F., Newman-Tancredi, A., Nury, H., Roberts, A., Roth, B. L., Roumier, A., Sanger, G. J., Teitler, M., Sharp, T., Villalón, C. M., Vogel, H., Watts, S. W., & Hoyer, D.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 73
- Issue
- 1
- Pages
- 310-520
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W3116452987
- Cited by
- 263
- References
- 2,264
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.